Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC

Clinical trial NCT05910034 · UNKNOWN

Trial details

NCT number: NCT05910034
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non-Small Cell Lung Cancer

Start date: 2023-07-01
Primary completion: 2025-12-30
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.